Accurate information on the health burden of vaccine-preventable infections (VPIs) is needed to support evidence-informed vaccine policy recommendations and programmes in Europe.

ESWI endorses a joint statement initiated by ERS and ELF to prioritise action to mitigate but also adapt to the health effects of climate change, to prepare societies and communities for a much more complex future.

People can be at risk of getting and spreading serious vaccine-preventable infectious diseases throughout their lives and can therefore benefit from a lifelong approach to vaccination.

The COST Action Promoting geriatric medicine in countries where it is still emerging (PROGRAMMING) has launched a survey aiming to map the educational interests and needs of current and future healthcare professionals in the field of care for older people

Vaccines that protect against any H1N1 influenza A virus strain would beadvantageous for use in pigs and humans.

An independent information document for nurses

Winter may be long gone and summer just around the corner, but the flu season is dragging on with all states continuing to record cases.

EHMA publishes a paper based on expert insight from across Europe, exploring the challenges and opportunities of implementing RSV immunisation programmes in different country contexts.

Mycoplasma pneumoniae is a common cause of respiratory tract infections with community-acquired pneumonia as the major disease-related burden.

Is there a difference between recommending flu, RSV and COVID-19 vaccinations in children? What is meant by preventing secondary diseases and other societal wider benefits? ...

Flu is the forgotten killer. What new vistas of vaccinology opened up after the COVID-19 pandemic? In what ways can flu treatments change as a consequence of lessons learned?